Expression of CHD1L in bladder cancer and its influence on prognosis and survival

CHD1L Is a Marker for Poor Prognosis of Hepatocellular Carcinoma after Surgical Resection

(2013) Jiyeon Hyeon et al.   Korean Journal of Pathology

CHD1L Protein is overexpressed in human ovarian carcinomas and is a novel predictive biomarker for patients survival

(2012) Wei-Peng He et al.   BMC CANCER

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

A pilot study of urinary microRNA as a biomarker for urothelial cancer

(2012) Jaime Snowdon et al.   CUAJ-Canadian Urological Association Journal

SPOCK1 Is Regulated by CHD1L and Blocks Apoptosis and Promotes HCC Cell Invasiveness and Metastasis in Mice

(2012) Yan Li et al.   GASTROENTEROLOGY

Biomarkers for prognosis and treatment selection in advanced bladder cancer patients

(2011) Yuanbin Ru et al.   CURRENT OPINION IN UROLOGY

Clinical significance of CHD1L in hepatocellular carcinoma and therapeutic potentials of virus-mediated CHD1L depletion

(2010) L. Chen et al.   GUT

CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients

(2010) Leilei Chen et al.   JOURNAL OF CLINICAL INVESTIGATION

Radical Cystectomy for Carcinoma of the Bladder: 2,720 Consecutive Cases 5 Years Later

(2008) Mohamed A. Ghoneim et al.   JOURNAL OF UROLOGY